The Reliance Foundation, the philanthropic arm of Mukesh Ambani’s Reliance Industries, has sought the government’s authorisation to import 20 lakh doses of US-based Johnson & Johnson’s Covid-19 vaccine for captive consumption and to inoculate its workforce pan-India, sources said.
“Reliance Foundation will import and receive the shipment of Johnson & Johnson’s Janssen Covid-19 vaccine from the USA with the purpose of captive consumption and to administer our entire workforce pan India. Import of this vaccine shall be administered within the organisation only and not at all for commercial purpose,” a source quoted the Reliance Foundation as having communicated to the health ministry.
The Foundation may source additional quantities too, the company is learnt to have said. It may also explore the possibility of importing jabs from other vaccine producers for internal use only, the organisation has said.